{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:57:07Z","timestamp":1777906627786,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T00:00:00Z","timestamp":1510358400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Hospital Organization, Okayama Medical Center"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s12098-017-2509-8","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T20:23:15Z","timestamp":1510345395000},"page":"261-265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effects of Growth Hormone Treatment on Lipid Profiles"],"prefix":"10.1007","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1462-3853","authenticated-orcid":false,"given":"Toshihide","family":"Kubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahoko","family":"Furujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyohei","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Hyodo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Fujinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Urayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,11]]},"reference":[{"key":"2509_CR1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1507\/endocrj.K03-115","volume":"53","author":"E Itoh","year":"2006","unstructured":"Itoh E, Hizuka N, Fukuda I, Takano K. Metabolic disorders in adult growth hormone deficiency; a study of 110 patients at a single institute in Japan. Endocr J. 2006;53:539\u201345.","journal-title":"Endocr J"},{"key":"2509_CR2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1210\/jc.2012-2940","volume":"98","author":"KM Claessen","year":"2013","unstructured":"Claessen KM, Appleman-Dijkstra NM, Adoptie DMMM, et al. Metabolic profile in growth horomone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy. J Clin Endocrinol Metab. 2013;98:352\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"2509_CR3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1210\/jc.2013-2394","volume":"99","author":"C Gazzaruso","year":"2014","unstructured":"Gazzaruso C, Gola M, Karamouzis I, Giubbini R, Giustina A. Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH-an update. J Clin Endocrinol Metab. 2014;99:18\u201329.","journal-title":"J Clin Endocrinol Metab"},{"key":"2509_CR4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2176\/nmc.ra.2014-0088","volume":"54","author":"I Fukuda","year":"2014","unstructured":"Fukuda I, Hizuka N, Muraoka T, Ichihara A. Adult growth hormone deficiency: current concepts. Neurol Med Chir (Tokyo). 2014;54:599\u2013605.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"2509_CR5","first-page":"39","volume":"123","author":"I Uzunova","year":"2015","unstructured":"Uzunova I, Kirilov G, Zacharieva S, Shinkov A, Borissova A-M, Klinov K. Individual risk factors of the metabolic syndrome in adult patients with growth hormone deficiency-a cross-sectional case-control study. Exp Clin Endocrinol Diabetes. 2015;123:39\u201343.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2509_CR6","doi-asserted-by":"crossref","unstructured":"Chihara K, Koledova E, Shimatus A, et al. An individualized GH dose regimen for long-term GH treatment in Japanese patients with adult GH deficiency. Eur J Endocrinol. 2005;153:57\u201365.","DOI":"10.1530\/eje.1.01936"},{"key":"2509_CR7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1210\/jcem.86.3.7268","volume":"86","author":"R Lanes","year":"2001","unstructured":"Lanes R, Gunczler P, Lopez E, Esaa S, Villaroel O, Revel-Chion R. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents. J Clin Endocrinol Metab. 2001;86:1061\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"2509_CR8","first-page":"207","volume":"58","author":"IM Sluis van der","year":"2002","unstructured":"van der Sluis IM, Boot AM, Hop WC, de Rijke YB, Krenning EP, de Muinck K-SSMPF. Long-term effects of growthhormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficeient children: a 9-year follow-up study. Horm Res. 2002;58:207\u201314.","journal-title":"Horm Res"},{"key":"2509_CR9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1365-2265.2004.02026.x","volume":"60","author":"M Salerno","year":"2004","unstructured":"Salerno M, Esposito V, Spinelli L, et al. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy. Clin Endocrinol. 2004;60:630\u20136.","journal-title":"Clin Endocrinol"},{"key":"2509_CR10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/eje.1.02343","volume":"156","author":"A Ciresi","year":"2007","unstructured":"Ciresi A, Amatto MC, Criscimanna A, et al. Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency. Eur J Endocrinol. 2007;156:353\u201360.","journal-title":"Eur J Endocrinol"},{"key":"2509_CR11","first-page":"219","volume":"46","author":"C Meazza","year":"2014","unstructured":"Meazza C, Elsedfy HH, Pagani S, Bozzola E, El Kholy M, Bozzola M. Metabolic parameters and adipokine profile in growth hormone deficient (GHD) children before and after 12-month GH treatment. Horm Metab Res. 2014;46:219\u201323.","journal-title":"Horm Metab Res"},{"key":"2509_CR12","first-page":"909","volume":"27","author":"C Foster","year":"2014","unstructured":"Foster C, Burton A, Scholl J, Scott ML, Gunter V, McCormick K. Lipid patterns in treated growth hormone deficient children vs. short stature controls. J Pediatr Endocri Met. 2014;27:909\u201314.","journal-title":"J Pediatr Endocri Met"},{"key":"2509_CR13","first-page":"3890","volume":"83","author":"R Kuromaru","year":"1998","unstructured":"Kuromaru R, Kohno H, Ueyama N, Hassan HMS, Honda S, Hara T. Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabokic effects. J Clin Endocrinol Metab. 1998;83:3890\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"2509_CR14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1203\/00006450-200011000-00012","volume":"48","author":"S Tenhola","year":"2000","unstructured":"Tenhola S, Martikainen A, Rahiala E, Herrg\u00e5rd E, Halonen P, Voutilainen R. Serum lipid concentrations and growth characteristics in 12-year-old children born small for gestational age. Pediatr Res. 2000;48:623\u20138.","journal-title":"Pediatr Res"},{"key":"2509_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-3016.2007.00895.x","volume":"22","author":"C Ogden","year":"2008","unstructured":"Ogden C, Schoendorf KC, Kiely JL, Gillman MW. Fetal growth and childhood cholesterol levels in the United States. Pediatr Perinat Epidemiol. 2008;22:5\u201311.","journal-title":"Pediatr Perinat Epidemiol"},{"key":"2509_CR16","first-page":"3786","volume":"85","author":"T Sas","year":"2000","unstructured":"Sas T, Mulder P, Hokken-Koelega A. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency. J Clin Endocrinol Metab. 2000;85:3786\u201392.","journal-title":"J Clin Endocrinol Metab"},{"key":"2509_CR17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1210\/jc.2006-1073","volume":"92","author":"M Dijk van","year":"2007","unstructured":"van Dijk M, Bannink EMN, van Pareren YK, Muldre PGH, Hokken-Koelega ACS. Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (SGA) and untreated short SGA controls. J Clin Endocrinol Metab. 2007;92:160\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"2509_CR18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000358196","volume":"81","author":"AM Kappelgaard","year":"2014","unstructured":"Kappelgaard AM, Kiyomi F, Horikawa R, Yokoya S, Tanaka T. The impact of long-term growth hormone treatment on metabolic parameters in Japanese patients with short stature born small for gestational age. Horm Res Paediatr. 2014;81:272\u20139.","journal-title":"Horm Res Paediatr."},{"key":"2509_CR19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000334152","volume":"76","author":"T Tanaka","year":"2011","unstructured":"Tanaka T, Yokoya S, Seino Y, et al. Long-term efficacy and safety of two doses of growth hormone in short Japanese children born small for gestational age. Horm Res Paediatr. 2011;76:411\u20138.","journal-title":"Horm Res Paediatr"},{"key":"2509_CR20","first-page":"6","volume":"64","author":"T Tanaka","year":"2005","unstructured":"Tanaka T, Tachibana K, Shimatsu A, et al. A nationwide attempt to standardize growth hormone assays. Horm Res. 2005;64:6\u201311.","journal-title":"Horm Res"},{"key":"2509_CR21","unstructured":"Approved Guideline - Evaluation of precision performance of clinical chemistry devices, EP5-A. 1999. National Committee for Clinical Laboratory Standards"},{"key":"2509_CR22","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1515\/CCLM.2011.201","volume":"49","author":"A M\u00fcller","year":"2011","unstructured":"M\u00fcller A, Scholz M, Blankenstein O, et al. Harmonization of growth hormone measurements with different immunoassays by data adjustment. Clin Chem Lab Med. 2011;49:1135\u201342.","journal-title":"Clin Chem Lab Med"},{"key":"2509_CR23","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1507\/endocrj.EJ16-0198","volume":"63","author":"N Katsumata","year":"2016","unstructured":"Katsumata N, Shimatsu A, Tachibana K, et al. Continuing efforts to standardize measured serum growth hormone values in Japan. Endocr J. 2016;63:933\u20136.","journal-title":"Endocr J"},{"key":"2509_CR24","first-page":"77","volume":"30","author":"T Kubo","year":"2017","unstructured":"Kubo T, Takahashi K, Furujo M, et al. Usefulness of non-fasting lipid parameters in children. J Pediatr Endocrinol Met. 2017;30:77\u201383.","journal-title":"J Pediatr Endocrinol Met."},{"key":"2509_CR25","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1046\/j.1442-200X.2003.01795.x","volume":"45","author":"K Asayama","year":"2003","unstructured":"Asayama K, Ozeki T, Sugihara S, et al. Criteria for medical intervention in obese children: a new definition of \u2018obesity disease\u2019 in Japanese children. Pediatric Int. 2003;45:642\u20136.","journal-title":"Pediatric Int."},{"key":"2509_CR26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1442-200X.2002.01634.x","volume":"44","author":"T Okada","year":"2002","unstructured":"Okada T, Murata M, Yamaguchi K, Harada K. New criteria of normal serum lipid levels in Japanese children: the nationwide study. Pediatr Int. 2002;44:596\u2013601.","journal-title":"Pediatr Int"},{"key":"2509_CR27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.5551\/jat.28100","volume":"22","author":"Y Abe","year":"2015","unstructured":"Abe Y, Okada T, Sugiura R, Yamauchi K, Murata M. Reference ranges for the non-high-density lipoprotein cholesterol levels in Japanese children and adolescents. J Atheroscler Thromb. 2015;22:669\u201375.","journal-title":"J Atheroscler Thromb"},{"key":"2509_CR28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/01.ATV.0000110657.67317.90","volume":"24","author":"S Lind","year":"2004","unstructured":"Lind S, Rudling M, Ericsson S, Olivecrona H, et al. Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humans. Arterioscler Thromb Vasc Biol. 2004;24:349\u201356.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2509_CR29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0021-9150(00)00433-0","volume":"153","author":"JA Beentjes","year":"2000","unstructured":"Beentjes JA, van Tol A, Sluiter WJ, Dullaart RP. Low plasma lecithin: cholesterol acyltransferase and lipid transfer protein activates in growth hormone deficient and acromegalic men: role in altered high density lipoproteins. Atherosclerosis. 2000;153:491\u20138.","journal-title":"Atherosclerosis"},{"key":"2509_CR30","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/oxfordjournals.aje.a114158","volume":"122","author":"GS Tell","year":"1985","unstructured":"Tell GS, Mittelmark MB, Vellar OD. Cholesterol, high density lipoprotein cholesterol and triglycerides during puberty: the Oslo Youth study. Am J Epidemiol. 1985;122:750\u201361.","journal-title":"Am J Epidemiol"},{"key":"2509_CR31","doi-asserted-by":"crossref","unstructured":"Finkelstein JW, Roffwarg HP, Boyard RM, Kream J, Hellman L. Age-related changes in the twenty-four-hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab. 1972;35:665\u201370.","DOI":"10.1210\/jcem-35-5-665"},{"key":"2509_CR32","first-page":"336","volume":"74","author":"PM Martha Jr","year":"1992","unstructured":"Martha PM Jr, Gorman KM, Blizzard RM, Rogol AD, Veldhuis JD. Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: relationship to age, pubertal status, and body mass. J Clin Endocrinol Metab. 1992;74:336\u201344.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-017-2509-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-017-2509-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-017-2509-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T00:52:00Z","timestamp":1521593520000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-017-2509-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,11]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["2509"],"URL":"https:\/\/doi.org\/10.1007\/s12098-017-2509-8","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,11]]}}}